AI assistant
Salzer Electronics Ltd. Earnings Release 2026
61391_rns_2026-05-25_92aad924-dd82-4e42-a373-a68f2f06d6bc.pdf
Earnings Release
Open in viewerOpens in your device viewer
SALZER
SALZER ELECTRONICS LTD
Regd. Office : Samichettipalayam, Jothipuram (Post)
Coimbatore -641 047.
CIN: L03210TZ1985PLC001535.
Phone No.0422-4233600/614/696
E-Mail: [email protected]
web site: https://www.salzergroup.net/
May 25, 2026
To
THE CORPORATE RELATIONSHIP DEPT
M/s.BSE Limited
I Floor, New Trading Ring,
Rotunda Building,
P.J.Towers, Dalal Street,
Fort, Mumbai - 400 001.
M/s. NATIONAL STOCK EXCHANGE OF INDIA LTD.,
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051
Tel: +91 22 26598235/36, 26598346
Fax: +91 22 26598237/38
SCRIP CODE: 517059
Symbol: SALZERELEC
Dear Sir,
Sub: Information pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we enclosed herewith the paper clippings of our Advertisement published in Tamil & English Daily, the Audited Financial Result for the Fourth quarter / Year ended 31.03.2026. The same is being posted in the company's website.
This is for your information and dissemination.
Thanking you,
Yours faithfully,
For SALZER ELECTRONICS LIMITED
MURUGE
SAN.K.M.
K M MURUGESAN
COMPANY SECRETARY
& COMPLIANCE OFFICER
ACS: 25953
Encl: as above
SUNDAY, MAY 26, 2016
WWW.FINANCIALEXPRESS.COM
FE SUNDAY
BELDING INDIA LTD
(Formerly known as Syntheis Falls Limited)
Regd. Off.: 9th Floor, VB Capitol Building, Range Hill Road, Opp. Hotel Symphony, Shostanagar, Shivajinagar, Pune-411007, Maharashtra, India I CIR: L63119PN1964PLC248366
Contact No.: +91 9156428663 | Email Id: [email protected] | Website: www.belding.ltd
STATEMENT OF AUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026
The Board of Directors of the Company, at their meeting held on May 22, 2026, approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026 ("Financial Results").
The Audited Financial Results along with the Independent Auditor's Report issued by Mrs. Mehra Goel & Co., Statutory Auditors of the Company is available on the Company's website at: https://www.belding.ltd/wp-content/uploads/2026/05/Financial-Results.pdf and which can also be accessed through the QR code provided herein.
For and on behalf of Board of Directors of Belding India Limited
Sd:-
Abhishek Narbana
Managing Director
CIR: 91873097
TCC
TCC CONCEPT LIMITED
Regd. Office: 9th Floor, VB Capitol Building, Range Hill Road, Opp. Hotel Symphony, Shostanagar, Shivajinagar, Pune-411007, Maharashtra, India I CIR: L63119PN1964PLC248366
Tel.: 020 2952 0104 | Email Id: [email protected] | Website: www.tccdds.in
STATEMENT OF AUDITED (STANDALONE AND CONSOLIDATED) FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026
The Board of Directors of the Company at its meeting held on May 22, 2026, has approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026 ("Financial Results").
The Audited Financial Results along with the Independent Auditor's Report, issued by Mrs. Mehra Goel & Co., Statutory Auditors of the Company is available on the Company's website at: https://budd.jstine- content/uploads/2026/05/TCC_Financial_Results2026.pdf and which can also be accessed through the QR code provided herein.
For and on behalf of Board of Directors of TCC Concept Limited
Sd:-
Umesh Kumar Sahay
Chairman and Managing Director
CIR: 91733088
Date: May 23, 2026
Place: Pune
SOIZER ELECTRONICS LIMITED
CIR: I-202157211660PLC631020, SOMKONTYPALKAN, JOYARYAAN P027, COMMANDER: I-641847.
Sod: [email protected] | Website: www.sdeng.org.in
SUGGEST OF ADDITIVE GUARANTEE AND CIRCULATION THERAPICALLY, FOR THE QUARTER AND YEARS ENDED MARCH 31, 2026
(No. In-Lights except where stated.)
| Particulars | Standalone | Consolidated | Year ended | Year ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quarter ended | Year ended | Quarter ended | Quarter ended | Year ended | Year ended | |||||||
| 31-05-2026 | 31-11-2027 | 31-05-2026 | 31-05-2027 | 31-05-2028 | 31-05-2026 | 31-11-2027 | 31-05-2026 | 31-05-2027 | 31-05-2028 | 31-05-2029 | ||
| Audit | Un-Audited | Audited | Audited | Audited | Audited | Audited | Un-Audited | Audited | Audited | Audited | Audited | |
| 1 | Total Income from Operations | 46,242.00 | 41,219.60 | 39,518.70 | 171,694.60 | 139,005.71 | 47,147.30 | 42,432.50 | 37,821.50 | 175,867.30 | 142,382.60 | |
| 2 | No/ Profit for the period before Tax (After and Cefour/disky Beds) | 1,132.96 | 1,778.63 | 1,148.04 | 8,671.22 | 4,151.13 | 1,535.15 | 1,836.83 | 1,466.76 | 7,046.77 | 7,469.08 | |
| 3 | No/ Profit for the period before Tax (After and Cefour/disky Beds) | 1,132.96 | 1,778.63 | 1,148.04 | 7,642.45 | 8,245.43 | 1,235.15 | 1,836.83 | 1,466.76 | 7,346.77 | 7,469.08 | |
| 4 | Net Profit for the period after Tax (After Extraordinary Items) | 1,052.26 | 1,273.85 | 655.32 | 5,263.31 | 6,225.92 | 1,846.86 | 1,269.68 | 1,092.12 | 5,377.31 | 5,246.45 | |
| 5 | Total Extraordinary Income for the Period | 803.02 | 1,096.44 | 786.95 | 5,205.27 | 6,785.95 | 872.55 | 1,098.54 | 1,040.47 | 5,210.85 | 5,252.45 | |
| 6 | Paid Up Souris (More Capital) | 1,769.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | 1,766.27 | |
| 7 | Sundry & Society (Other equity) | - | - | - | 38,136.60 | 41,759.76 | - | - | - | 37,467.36 | 37,839.22 | |
| 8 | Earnings Per Share (20%) | 3.87 | 7.21 | 4.86 | 30.44 | 55.36 | 5.81 | 7.01 | 6.19 | 29.84 | 29.73 | |
| Social (40.5%) | 0.67 | 7.21 | 4.86 | 30.44 | 55.31 | 5.81 | 7.01 | 6.19 | 29.84 | 29.63 | ||
| The above is an extract of standards and consolidated financial Results for quarter and year ending March 31, 2026, as filed with the Stock Exchange under Reg D 4 and with Reg AT of GGM (Lading SRegations and Distributions, Regulon and Ex Regulation) (No. The headings of the aforesaid Financial Results are available on the Stock Exchange) and are under separate journal and street standards such and variable of the Company name addressing us as: |
QUINT DIGITAL LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
EXTRACT OF THE AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEARS ENDED MARCH 31, 2026
The Board of Directors of Belding Institute Limited (the Company) at its meeting held on May 22, 2026, approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2026.
The Results, along with Audit Report(s), by Mrs. MBNA & Associates LLC, the Statutory Auditor of the Company, and the Director of the Company, are presented as a final report of the Company, at www.multibaseindia.com and on website of the Stock Exchange at www.bseindia.com.
The names can be accessed by to promote the QR code provided.
In compliance with Regulation 47 of the 3830 Listing Regulations, we hereby notify that the same can also be accessed by scanning the following Quick response (CIR code):
Date: 24.05.2026
Place: Mankhal
"IMPORTANT"
Using it is not possible to verify the currently. This Indian Express-JPL Limited cannot be held responsible for such comments, nor for any loss or damage incurred as a result of transactions with companies, associations or individuals advertising in its newspapers or PUB stations. We therefore recommend that readers make a necessary inquiries before sending any monies or entering into any agreements with advertisers or otherwise acting on an advertisement in any manner whatsoever.
SMS PHARMACEUTICALS LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
| Estimated tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, are as, instead by the built Committee and the Director (see note 2) for the quarter and year ended March 31, 2026. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| The Stock Exchange includes the following (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, that with the BSD Limited under Regulation 23 of the 3830 Listing Obligations and Shortage Plan (see Note 1) (Regulation 2274). The full format of the audited tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at assessments connected to (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at assessments connected to (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at assessments connected to (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at |
SMS PHARMACEUTICALS LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
| Estimated tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, are as, instead by the built Committee and the Director (see note 2) for the quarter and year ended March 31, 2026. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| The Stock Exchange includes the following (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, that with the BSD Limited under Regulation 23 of the 3830 Listing Obligations and Shortage Plan (see Note 1) (Regulation 2274). The full format of the audited tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at assessments connected to (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at |
SMS PHARMACEUTICALS LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
| Estimated tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, as as, instead by the built Committee and the Director (see note 2) for the quarter and year ended March 31, 2026. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| The Stock Exchange includes the following (included tabulations and consolidated financial results for the quarter and financial year ended March 31, 2026, that with the BSD Limited under Regulation 23 of the 3830 Listing Obligations and Shortage Plan (see Note 1) (Regulation 2274). The full format of the audited tabulation and consolidated financial results for the quarter and financial year ended March 31, 2026, are available on the Schedule of the BSD Limited at |
DIVYASHAKTI LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
| DIVYASHAKTI LIMITED | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| The above Standards and consolidated Financial Results have been reviewed and recommended by the Audit Committee Meeting held on 21st May, 2026 and approved by the Board of Directors in their meeting held on 21st May, 2026 and Statutory Auditors of the Company have carried out a revised Review. | ||||||||||
| The rest of the 1000 items listed below are as, instead by the Audit Committee Meeting with the Board of Directors of the Company, as amended by the Board of Directors of the Company. | ||||||||||
| The rest of the 1000 items listed below are as, instead by the Audit Committee Meeting with the Board of Directors of the Company, as amended by the Board of Directors of the Company. |
SMS PHARMACEUTICALS LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
| DIVYASHAKTI LIMITED | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| The above Standards and consolidated Financial Results have been reviewed and recommended by the Audit Committee Meeting held on 21st May, 2026 and approved by the Board of Directors in their meeting held on 21st May, 2026 and Statutory Auditors of the Company have carried out a revised Review. | ||||||||||
| The rest of the 1000 items listed below are as, instead by the Audit Committee Meeting with the Board of Directors of the Company, as amended by the Board of Directors of the Company. |
SMS PHARMACEUTICALS LIMITED
Regd. Office: 403 Padma Khos 11, Rajasthan Road, Delhi 110008 Tel: 011-40160755
Date Office: 12/04/2026 | Schedule: 2026-05-04 | Sod: 2026-05-05 | Sod: 2026-05-05
ஞாயிற்றுக்கிழமை, 24 மே 2026
தவிதமும்
1
தினமணி கோவை 5
கோவை சிறும் கொலை சம்பவம்
கேள்வி மணி துணைம் கண்டனம்
முது. திரு.ச
புத்திரன்.மே.23 கோவையில் சிறுமி கடத்தப்பட்டு கோவை செல்லப்பட்ட சம்பவத்துக்கு கேள்வி மணி துணைம் கண்டனம் கேள்வித்துள்ளது.
இதனுக்கு கேள்வி மணி துணைமதின் தலைவர் விஜயா ரமுத்ரா சனிக்கிழமை வெளியிட்ட அறிக்கையில் கற்பப்பட்டு வந்துள்ளது.
தமிழ்நாட்டின் கோவையில் 10 ஊது சிறுமி கடத்தப்பட்டு கோபுரமாக கோவை செல்லப்பட்ட குற்றத் வேத விசாரணை சம்பவத்தை கேள்வி மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது. இந்த வழக்கில் உடனடியாக கற்பிக்குமான மற்றும் காவலிக்குறியத்துக்கு காவல்துறை தலைமை இயக்குநர் பழுதிரி நடவடிக்கை எடுக்க வேண்டும். ஏழு நான்கு துணை விஸ்வான் நடவடிக்கை எடுக்கப்பட்டு, அறிக்கையை மாடுது துணைம் கோவிந்துள்ளது.
இந்த வழக்கில் பதிவு செய்யப்பட்ட சம்பெறு பழுதிரி பாரதம் திரு.ச.என்.என்.என் மற்றும் பி.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.என்.
இந்த வழக்கில் கேள்வி மணி துணைமதின் தலைவர் விஜயா ரமுத்ரா சனிக்கிழமை வெளியிட்டு கேள்வி மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 பாலின வங்கி செல்லப்பட்ட சம்பவத்துக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி (மே. 23) 1986-87ம் ஆண்டு மார்ச் 22-ம் தேதி கிழக்கிந்தியாவில் கோவிலில் உள்ள மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது. இந்த வழக்கில் கொலை சம்பவத்துக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி (மே. 23) 1986-87ம் ஆண்டு மார்ச் 22-ம் தேதி கிழக்கிந்தியாவில் கோவிலில் உள்ள மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
கோவை மே 23 மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 பாலின வங்கி செல்லப்பட்ட சம்பவத்துக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி (மே. 23) 1986-87ம் ஆண்டு மார்ச் 22-ம் தேதி கிழக்கிந்தியாவில் கோவிலில் உள்ள மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.
திறந்தவளிக்குக்கு அதிகபட்ச தண்டனை பெற்றுத் தரப்படும் அவசரச் சம்பவத்தான உறுதி
கோவை மே 23 மணி துணைமதின் தலைவர் தில் கோவிந்துள்ளது.